MicroRNAs Regulate Signaling Pathways in Osteogenic Differentiation of Mesenchymal Stem Cells (Review)
Overview
Affiliations
Osteogenesis is a complex multi-step process involving the differentiation of mesenchymal stem cells (MSCs) into osteoblast progenitor cells, preosteoblasts, osteoblasts and osteocytes, and the crosstalk between multiple cell types for the formation and remodeling of bone. The signaling regulatory networks during osteogenesis include various components, including growth factors, transcription factors, micro (mi)RNAs and effectors, a number of which form feedback loops controlling the balance of osteogenic differentiation by positive or negative regulation. miRNAs have been found to be important regulators of osteogenic signaling pathways in multiple aspects and multiple signaling pathways. The present review focusses on the progress in elucidating the role of miRNA in the osteogenesis signaling networks of MSCs as a substitute for bone implantation the the field of bone tissue engineering. In particular, the review classifies which miRNAs promote or suppress the osteogenic process, and summarizes which signaling pathway these miRNAs are involved in. Improvements in knowledge of the characteristics of miRNAs in osteogenesis provide an important step for their application in translational investigations of bone tissue engineering and bone disease.
Yalaev B, Kaletnik E, Karpova Y, Belaya Z, Minniakhmetov I, Mokrysheva N Noncoding RNA. 2025; 11(1).
PMID: 39997614 PMC: 11858178. DOI: 10.3390/ncrna11010014.
Aranguren S, Cole H, Dargan L, Sarlo M, Choi S, Satapathy I Front Cell Dev Biol. 2025; 12():1483843.
PMID: 39834390 PMC: 11743950. DOI: 10.3389/fcell.2024.1483843.
Song M, Yang X, Zhang X, Li J, Xu Y, Shi J Ann Med. 2024; 56(1):2395591.
PMID: 39444146 PMC: 11504341. DOI: 10.1080/07853890.2024.2395591.
Jimenez-Ortega R, Ortega-Melendez A, Patino N, Rivera-Paredez B, Hidalgo-Bravo A, Velazquez-Cruz R Biology (Basel). 2024; 13(7).
PMID: 39056698 PMC: 11273958. DOI: 10.3390/biology13070505.
miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.
Tavakoli Pirzaman A, Ebrahimi P, Hasanpour A, Shakeri M, Babajani B, Pourali Ganji Z Technol Cancer Res Treat. 2023; 22:15330338231202391.
PMID: 37728167 PMC: 10515583. DOI: 10.1177/15330338231202391.